To further evaluate the impact of the ECM environment on CRC liver metastasis, we performed immunohistochemical staining on liver metastases to assess the expression of HSF4, LOXL1, MASSON, and α-SMA. The gene discussed is HSF4; the disease is colorectal carcinoma.